N-[(1S)-2-Amino-1-methylethyl]-carbamic acid methyl ester hydrochloride, commonly known as a chiral intermediate, plays a critical role in the synthesis of pharmaceuticals, particularly in the development of drugs targeting neurological and cardiovascular conditions. This compound is a hydrochloride salt, enhancing its stability and solubility, making it suitable for use in complex organic synthesis.
The discovery of N-[(1S)-2-Amino-1-methylethyl]-carbamic acid methyl ester hydrochloride can be traced to efforts aimed at synthesizing enantiomerically pure intermediates for use in asymmetric synthesis. Its structural characteristics, including the presence of a chiral center, allow it to serve as a building block in the preparation of optically active pharmaceutical agents.
Synthesis of this compound typically involves the reaction of isopropylamine with methyl chloroformate in the presence of hydrochloric acid. This method is both efficient and scalable, contributing to the widespread application of the compound in industrial settings. The resulting product exhibits high purity and enantiomeric excess, which is crucial for the downstream synthesis of target pharmaceuticals.
Applications of N-[(1S)-2-Amino-1-methylethyl]-carbamic acid methyl ester hydrochloride extend to the development of drugs for the treatment of hypertension, neurological disorders, and metabolic diseases. Its role as a key intermediate in the synthesis of enzyme inhibitors and receptor modulators underscores its importance in medicinal chemistry.
References
none
|
![CAS # 1229025-32-4, N-[(1S)-2-Amino-1-methylethyl]-carbamic acid methyl ester hydrochloride (1:1)](/structures/1229025-32-4.gif)
GHS07 Warning Details
Discovery and Applications